MRVL Marvell Technology, Inc.
Semiconductors & Related Devices · Nasdaq · SEC CIK 1835632 · Fiscal year ends 01/30
Financial factors as of 2026-08-01 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY30.6%
TTM net income YoY2,653.1%
TTM EPS YoY2,616.7%
Revenue 3-yr CAGR18.9%
Net income 3-yr CAGR—
Margins
Gross margin52.2%
Operating margin16.5%
Net margin27.9%
FCF margin18.3%
EBITDA margin—
Returns
ROE16.5%
ROA11.0%
ROIC (approx.)6.8%
Asset turnover0.39x
Leverage & solvency
Liabilities / assets32.7%
Debt / equity0.27x
Current ratio3.17x
Interest coverage7.21x
Cash quality & payout
Operating cash flow / net income0.83x
Accruals ratio1.8%
Payout ratio7.9%
Capex / revenue5.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-01-31 | FY20252025-02-01 |
|---|---|---|
| Income statement | ||
| Revenue | $8.19B | $5.77B |
| Cost of revenue | $4.01B | $3.39B |
| Gross profit | $4.18B | $2.38B |
| R&D expense | $2.08B | $1.95B |
| SG&A expense | $767.10M | $798.20M |
| Operating income | $1.32B | -$720.30M |
| Interest expense | $202.60M | $189.40M |
| Pretax income | $3.05B | -$894.70M |
| Income tax | $376.50M | -$9.70M |
| Net income | $2.67B | -$885.00M |
| EBITDA | $1.54B | -$543.30M |
| EPS (basic) | 3.10 | -1.02 |
| EPS (diluted) | 3.07 | -1.02 |
| Dividends declared per share | 0.24 | 0.24 |
| Weighted avg. shares (diluted) | 869.70M | 865.50M |
| Balance sheet | ||
| Cash & equivalents | $2.64B | $948.30M |
| Receivables | $2.19B | $1.03B |
| Inventory | $1.39B | $1.03B |
| Current assets | $6.46B | $3.12B |
| PP&E, net | $935.00M | $790.50M |
| Goodwill | $11.06B | $11.59B |
| Intangibles | $1.75B | $2.71B |
| Total assets | $22.29B | $20.20B |
| Current liabilities | $3.22B | $2.03B |
| Short-term debt | $499.80M | $129.50M |
| Long-term debt | $3.97B | $3.93B |
| Total debt | $4.47B | $4.06B |
| Total liabilities | $7.98B | $6.78B |
| Shareholders' equity | $14.31B | $13.43B |
| Net debt | $1.83B | $3.12B |
| Shares outstanding | 847.30M | 866.00M |
| Cash flow statement | ||
| Operating cash flow | $1.75B | $1.68B |
| Capital expenditure | $354.10M | $284.60M |
| Free cash flow | $1.40B | $1.40B |
| Investing cash flow | $2.10B | -$300.70M |
| Financing cash flow | -$2.16B | -$1.38B |
| Depreciation & amortization | $221.70M | $177.00M |
| Stock-based compensation | $590.80M | $597.40M |
| Dividends paid | $205.10M | $207.50M |
| Share buybacks | $2.04B | $725.00M |
Free plan shows the latest 2 periods; Pro shows all 7 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.